Jan Willem Nieuwenhuize
Inversor de Capital Privado en ING Corporate Investments BV .
Perfil
Jan Willem Nieuwenhuize is currently the Managing Director at ING Corporate Investments BV since 2017.
Previously, he worked as a Director at Agendia, Inc. and as a Member-Supervisory Board at Agendia NV.
Cargos activos de Jan Willem Nieuwenhuize
Empresas | Cargo | Inicio |
---|---|---|
ING Corporate Investments BV
ING Corporate Investments BV Investment ManagersFinance ING Corporate Investments BV is a Private Equity/Venture Capital firm, a subsidiary of ING Groep NV founded in 1990. ING Corporate Investments BV is headquartered in Amsterdam. | Inversor de Capital Privado | 01/06/2007 |
Antiguos cargos conocidos de Jan Willem Nieuwenhuize.
Empresas | Cargo | Fin |
---|---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Director/Miembro de la Junta | - |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
ING Corporate Investments BV
ING Corporate Investments BV Investment ManagersFinance ING Corporate Investments BV is a Private Equity/Venture Capital firm, a subsidiary of ING Groep NV founded in 1990. ING Corporate Investments BV is headquartered in Amsterdam. | Finance |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jan Willem Nieuwenhuize